Literature DB >> 20961759

Prevalence, mutation spectrum and phenotypic variability in Norwegian patients with Limb Girdle Muscular Dystrophy 2I.

Eva Stensland1, Sigurd Lindal, Christoffer Jonsrud, Torberg Torbergsen, Laurence A Bindoff, Magnhild Rasmussen, Arve Dahl, Frances Thyssen, Øivind Nilssen.   

Abstract

Mutations in the FKRP (Fukutin Related Protein) gene produce a range of phenotypes including Limb Girdle Muscular Dystrophy Type 2I (LGMD2I). In order to investigate the prevalence, the mutation spectrum and possible genotype-phenotype correlation, we studied a cohort of Norwegian patients with LGMD2I, ascertained in a 4-year period. In this retrospective study of genetically tested patients, we identified 88 patients from 69 families, who were either homozygous or compound heterozygous for FKRP mutations. This gives a minimum prevalence of 1/54,000 and a corresponding carrier frequency of 1/116 in the Norwegian population. Seven different FKRP mutations, including three novel changes, were detected. Seventy-six patients were homozygous for the common c.826C>A mutation. These patients had later disease onset than patients who were compound heterozygous - 14.0 vs. 6.1 years. We detected substantial variability in disease severity among homozygous patients.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20961759     DOI: 10.1016/j.nmd.2010.08.008

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  24 in total

1.  Obstetric management of a woman with limb-girdle muscular dystrophy type 2i and dilated cardiomyopathy.

Authors:  Alexandra von Guionneau; Charlotte Burford; Sophia Stone
Journal:  Obstet Med       Date:  2018-12-11

2.  AAV-mediated transfer of FKRP shows therapeutic efficacy in a murine model but requires control of gene expression.

Authors:  Evelyne Gicquel; Natacha Maizonnier; Steven J Foltz; William J Martin; Nathalie Bourg; Fedor Svinartchouk; Karine Charton; Aaron M Beedle; Isabelle Richard
Journal:  Hum Mol Genet       Date:  2017-05-15       Impact factor: 6.150

3.  Diagnostic delay in patients with FKRP-related muscular dystrophy.

Authors:  Lauren N Coffey; Carrie M Stephan; M B Zimmerman; Chyan K Decker; Katherine D Mathews
Journal:  Neuromuscul Disord       Date:  2021-09-06       Impact factor: 4.296

4.  The outcomes and experience of pregnancy in limb girdle muscular dystrophy type R9.

Authors:  Eric M Libell; Noelle C Bowdler; Carrie M Stephan; Miriam Bridget Zimmerman; Amber M Gedlinske; Katherine D Mathews
Journal:  Muscle Nerve       Date:  2021-02-10       Impact factor: 3.852

Review 5.  Genetic basis of limb-girdle muscular dystrophies: the 2014 update.

Authors:  Vincenzo Nigro; Marco Savarese
Journal:  Acta Myol       Date:  2014-05

Review 6.  A Journey with LGMD: From Protein Abnormalities to Patient Impact.

Authors:  Dimitra G Georganopoulou; Vasilis G Moisiadis; Firhan A Malik; Ali Mohajer; Tanya M Dashevsky; Shirley T Wuu; Chih-Kao Hu
Journal:  Protein J       Date:  2021-06-10       Impact factor: 2.371

Review 7.  Therapeutic advances in muscular dystrophy.

Authors:  Doris G Leung; Kathryn R Wagner
Journal:  Ann Neurol       Date:  2013-09       Impact factor: 10.422

Review 8.  Limb-girdle muscular dystrophies: where next after six decades from the first proposal (Review).

Authors:  Omar A Mahmood; Xin Mei Jiang
Journal:  Mol Med Rep       Date:  2014-03-13       Impact factor: 2.952

9.  Limb-girdle muscular dystrophy subtypes: First-reported cohort from northeastern China.

Authors:  Omar Abdulmonem Mahmood; Xinmei Jiang; Qi Zhang
Journal:  Neural Regen Res       Date:  2013-07-15       Impact factor: 5.135

10.  First Identification of Compound Heterozygous FKRP Mutations in a Korean Patient with Limb-Girdle Muscular Dystrophy.

Authors:  Hyung Jun Park; Jung Hwan Lee; Ha Young Shin; Seung Min Kim; Ji Hyun Lee; Young Chul Choi
Journal:  J Clin Neurol       Date:  2015-08-21       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.